Clinical Trial on the Effects of Caffeine and Taurine From Energy Drinks (EDs) to Parameters of the Cardiovascular System in Humans
Not Applicable
Completed
- Conditions
- Cardiovascular Risk
- Interventions
- Dietary Supplement: Energy Drink, Taurine, Caffeine
- Registration Number
- NCT01421979
- Lead Sponsor
- University of Hohenheim
- Brief Summary
The aim of this study is to examine the safety and the effects of EDs at high doses, either alone or in combination with other risk factors such as alcohol intake, physical exercise and sleep deprivation, on cardiovascular markers and subjective health.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 38
Inclusion Criteria
- written informed consent
- healthy (no acute or chronic desease)
- BMI 20,0 - 25,9 kg/m2
- moderate and non-regular consumption of alcohol, EDs and coffee
Exclusion Criteria
- pregnancy
- regular medication (oral contraceptives permitted)
- hypertension and other deseases of the cardiovascular system
- liver-deseases
- psychiatric deseases
- epilepsy
- other relevant deseases
- (former) alcoholics
- non-compliance to the study-protocol
- simultaneous participation in another clinical trial
- retraction of the written informed consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description exposure under sleep deprivation Energy Drink, Taurine, Caffeine Examination of the effects of EDs in combination with alcohol consumption and sleep deprivation. Exercise after consumption Energy Drink, Taurine, Caffeine Examination of the effects of EDs in combination with alcohol consumption and exercise.
- Primary Outcome Measures
Name Time Method Heart-rate-variability (HRV) during 24 hours
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Hohenheim
🇩🇪Stuttgart, Baden-Württemberg, Germany